Table 2 Incidence of dose reduction, suspension, or discontinuation of chemotherapya in patients with chemotherapy-induced peripheral neuropathy (full analysis set, n = 52)
Event | n (%) |
|---|---|
Due to all causes | |
 No dose reduction, suspension, or discontinuation | 20 (38.5) |
  Dose reduction | 4 (7.7) |
  Suspension | 12 (23.1) |
  Discontinuation | 18 (34.6) |
Due to CIPN | |
 No dose reduction, suspension, or discontinuation | 46 (88.5) |
  Dose reduction | 3 (5.8) |
  Suspension | 1 (1.9) |
  Discontinuation | 2 (3.8) |